ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 174 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $95,351,000 | -50.8% | 1,783,935 | +4.0% | 0.02% | -51.1% |
| Q4 2015 | $193,833,000 | -8.4% | 1,715,796 | -4.5% | 0.04% | -18.2% |
| Q3 2015 | $211,546,000 | +48.6% | 1,797,176 | -2.3% | 0.06% | +61.8% |
| Q2 2015 | $142,387,000 | +40.5% | 1,838,909 | +5.0% | 0.03% | +41.7% |
| Q1 2015 | $101,337,000 | +79.2% | 1,751,717 | -0.1% | 0.02% | +71.4% |
| Q4 2014 | $56,534,000 | +42.1% | 1,752,982 | +7.8% | 0.01% | +27.3% |
| Q3 2014 | $39,795,000 | +72.1% | 1,626,258 | +24.7% | 0.01% | +57.1% |
| Q2 2014 | $23,124,000 | -4.0% | 1,304,235 | +8.3% | 0.01% | 0.0% |
| Q1 2014 | $24,096,000 | +24.6% | 1,204,181 | +4.4% | 0.01% | +16.7% |
| Q4 2013 | $19,346,000 | +57.5% | 1,152,930 | -0.3% | 0.01% | +50.0% |
| Q3 2013 | $12,280,000 | +118.7% | 1,156,322 | +15.1% | 0.00% | +100.0% |
| Q2 2013 | $5,616,000 | – | 1,004,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 54,476 | $5,407,000 | 0.30% |
| CIM INVESTMENT MANAGEMENT INC | 3,377 | $335,000 | 0.14% |
| EQUITEC SPECIALISTS, LLC | 69,000 | $0 | 0.00% |
| EQUITEC SPECIALISTS, LLC | 55,700 | $0 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |